Publication Catalogue

Publications of the Department of Vaccines 2008

A. Original articles and reviews

  1. DeStefano F, Pfeifer D, Nohynek H: Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. BULL WORLD HEALTH ORGAN 2008;86:373-380.
  2. Honkanen J, Skarsvik S, Knip M, Vaarala O: Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes. Diabetes/metabolism research and reviews 2008;24:635-641.
  3. Kaijalainen T, Kharit SM, Kvetnaya AS, Sirkiä K, Herva E, Parkov OV, Nohynek H: Invasive infections caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae among children in St Petersburg, Russia. Clinical microbiology and infection 2008;14:507-510.
  4. Kilpi TM, Silfverdal SA, Nilsson L, Syrjänen R, Belloni C, Desole M, Triban C, Storsaeter J, Soila M, Jacquet JM: Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age. Human Vaccines 2008(Jun 2).
  5. Leino T, Hoti F, Syrjänen A, Tansakanen A, Auranen K: Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres. BMC Infectious Diseases 2008;8:173.
  6. Madhi SA, Whitney CG, Nohynek H: Lessons learned from clinical trials evaluating pneumococcal conjugate vaccine efficacy against pneumonia and invasive disease. Vaccine 2008;26:B9-B15.
  7. Melin MM, Hollingshead SK, Briles DE, Lahdenkari MI, Kilpi TM, Käyhty HM: Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae. Clinical and Vaccine Immunology 2008(Aug 27).
  8. Melin MM, Hollingshead SK, Briles DE, Hanage WP, Lahdenkari M, Kaijalainen T, Kilpi TM, Käyhty HM: Distribution of pneumococcal surface protein A families 1 and 2 among Streptoccus pneumoniae isolates from children in Finland who had acute otitis media or were nasopharyngeal carriers. Clinical and Vaccine Immunology 2008;15:1555-1563.
  9. Palmu A, Jokinen J, Kilpi T: Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine. Vaccine 2008;26:2466-2470.
  10. Pietrzyk JJ, Wysocki J, Pejcz J, Galaj A, Majda-Stanislawska E, Käyhty H, Thierry-Carstensen B, Jenseng AM: Safety and immunogenicity of a DTaP-IPVvero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months o. Vaccine 2008;26:5296-5303.
  11. Puumalainen T, Quiambao B, Abucejo-Ladesma E, Lupisan S, Heiskanen-Kosma T, Ruutu P, Lucero MG, Nohynek H, Simoes EAF, Riley I: Clinical case review: A method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia. BMC Infectious Diseases 2008;21:95.
  12. Rigsby P, Ison C, Brierley M, Ballard R, Hagedorn HJ, Lewis DA, Notermans DW, Riis J, Robertson P, Seppälä IJ, Rijpkema S: Evaluation of two Human plasma pools as candidate International Standard Preparations for syphilitic antibodies. Clinical and Vaccine Immunology 2008(May 21).
  13. Savolainen-Kopra C, Blomqvist S, Kilpi T, Roivainen M, Hovi T: Human rhinoviruses in acute otitis media. Pediatr Infect Dis J 2008(Dec 3).
  14. Siljander, T, Karppelin, M, Vähäkuopus, S, Syrjänen, J, Toropainen, M, Kere, J, Vuento, R, Jussila, T, Vuopio-Varkila, J: Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis 2008;46:855-61.
  15. Simell B, Lahdenkari M, Reunanen A, Käyhty H, Väkeväinen M: Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clinical and Vaccine Immunology 2008;15:1391-1397.
  16. Toropainen M, Raitolehto A, Henckaerts I, Wauters D, Poolman J, Lestrate P, Käyhty H: Pneumococcal Haemophilus influenzae protein D conjugate vaccine induce antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D. Infect Immun 2008(Jul 21).
  17. Waldmann P, Hallander J, Hoti F, Sillanpää MJ: Efficient Markov chain Monte Carlo implementation of bayesian analysis of additive and dominance genetic variances in noninbred pedigrees. GENETICS 2008;179:1101-1112.
  18. West CE, Gothefors L, Granström M, Käyhty H, Hammarström ML, Hernell O: Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. PEDIATR ALLERGY IMMUNOL 2008;19:53-60.

C. Textbooks and chapters in textbooks, reports and proceedings

  1. Folkhälsoinstitutets arbetsgrupps utredning om vaccinering av barn mot rotavirus 26.11.2007. Helsingfors: Folkhäsoinstitutet, 2008. (Folkhälsoinstitutets publikationer B 17/2008).
  2. Influenssarokotussuositus Suomessa syys- ja talvikaudella 2008-2009. Helsinki: Kansanterveyslaitos, 2008. (Kansanterveyslaitoksen julkaisuja C 6/2008).
  3. Kansanterveyslaitoksen asettaman lasten pneumokokkirokotustyöryhmän selvitys. Helsinki: Kansanterveyslaitos, 2008. (Kansanterveyslaitoksen julkaisuja B 12/2008).
  4. Rekommendation om influensavaccinering i Finland under höst- och vintersesongen 2008-2009. Helsingfors: Folkhäsoinstitutet, 2008. (Folkhälsoinstitutets publikationer C 7/2008).
  5. Davidkin I, Heiskanen-Kosma T, Koski T, Leino T, Rosenberg L, Vesikari T, Vuorinen T, Salo H: Kansanterveyslaitoksen asettaman lasten vesirokkorokotustyöryhmän selvitys. Helsinki: Kansanterveyslaitos, 2008. (Kansanterveyslaitoksen julkaisuja B 40/2008).
  6. Jalava K, Lindström M, Ölander RM, Niskanen T, Korkeala H, Kuusi M: Anvisning om åtgärder vid botulism. Helsingfors: Folkhäsoinstitutet, 2008. (Folkhälsoinstitutets publikationer C 14/2008).
  7. Jalava K, Lindström M, Ölander R, Niskanen T, Korkeala H, Kuusi M: Toimenpideohje botulismitapausten varalta. Helsinki: Kansanterveyslaitos, 2008. (Kansanterveyslaitoksen julkaisuja C 5/2008).
  8. Kilpi T, Schuerman L: Acute Otitis Media and Its Sequelae. In: Siber G, Klugman K, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008.
  9. Kohlberger RC, Jokinen J, Siber GR: Establishing Immune Correlates of Protection. In: Siber G, Klugman K, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008.
  10. Käyhty H, Lockhart S, Schuerman L: Immunogenicity and reactogenicity of pneumococcal conjugate vaccines in infants and children. In: Siber G, Klugman K, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008.
  11. Madore DV, Quataert SA, Väkeväinen M: Quantitation of anti-pneumococcal capsular antibody in ligand-binding assays. In: Siber GR, Klugman KP, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008:199-211.
  12. Madore DV, Quataert SA, Väkeväinen M: Quantitation of Anti-Pneumococcal Capsular Antibody in Ligand-Binding Assays. In: Siber G, Klugman K, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008.
  13. Mäkelä H, Butler JC: History of Pneumococcal Immunization. In: Siber G, Klugman K, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008.
  14. O'Brien KL, Dagan R, Mäkelä H: Nasopharyngeal Carriage. In: Siber G, Klugman K, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008.
  15. Siber GR, Klugman KP, Mäkelä H: Conclusions. In: Siber G, Klugman K, Mäkelä PH ed. Pneumococcal Vaccines: the impact of conjugate vaccines. Washington DC: ASM Press, 2008.
  16. Snellman M: Case definition of Pneumococcal Pneumonia - a latent class analysis. Helsinki: Kansanterveyslaitos, 2008. (Kansanterveyslaitoksen julkaisuja B 3/2008).

D. Other publications

  1. Sinisalo M, Vilpo J, Itälä M, Väkeväinen M, Taurio J, Aittoniemi J: Efficacy of pneumococcal vaccination on chronic lymphocytic leukemia: Should we rely on surrogate markers? Reply. Vaccine 2008;26:3959-3959.

E. Theses

  1. Ahokas P: Lasten seerumin vasta-aineet Streptococcus pneumoniae-bakteerin PhtD- ja CbpA-pintaproteiineille sekä niiden yhteys pneumokokkikantajuuteen ja pneumokokin aiheuttamiin korvatulehduksiin [Pro gradu]. Helsinki: Helsingin yliopisto, 2008.
  2. Raitolehto A: Entsyymi-inhibitiomenetelmän kehittäminen Haemophilus influenzae-bakteerin proteiini D:n immunogeenisuuden mittaamiseksi [Pro gradu]. Helsinki: Helsingin yliopisto, 2008.
  3. Snellman M: Case definition of Pneumococcal pneumonia - a latent class analysis [Pro gradu] . Helsinki: National Public Health Institute, 2008. (Publications of the National Public Health Institute B 3/2008).